MNM integrates cutting-edge genomics with the latest technological breakthroughs in AI to fight cancer. Our goal is to crack the code of cancer biology.
Our proprietary platform applies AI to tumor's dark genome to personalize therapy for every cancer patient.
To fulfill our mission “precision therapy for every cancer patient” we have developed a set of specialized assets.
Explore our evidence-based knowledge in genomics and AI.
MNM is a biotech start-up created by an interdisciplinary team of experts from geneticists, to molecular biologists, bioinformaticians and AI specialists.
MNM received a Certificate of Conformity with the international ISO 9001: 2015 standard, which means that our organisation provides the highest level of quality, performance and practical handling.